Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP463182.RAcN3H14xNHHpDbRwdqlSVdhTY3LFZRVpEjd3C3ODxGyE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP463182.RAcN3H14xNHHpDbRwdqlSVdhTY3LFZRVpEjd3C3ODxGyE130_assertion type Assertion NP463182.RAcN3H14xNHHpDbRwdqlSVdhTY3LFZRVpEjd3C3ODxGyE130_head.
- NP463182.RAcN3H14xNHHpDbRwdqlSVdhTY3LFZRVpEjd3C3ODxGyE130_assertion description "[The oncogenic potential and apparent absence of physiologic defects in adult human tissues lacking GPR56, as well as the targetable nature of G protein - coupled receptor by small molecule or antibody, make GPR56 an attractive drug target for the development of cancer therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP463182.RAcN3H14xNHHpDbRwdqlSVdhTY3LFZRVpEjd3C3ODxGyE130_provenance.
- NP463182.RAcN3H14xNHHpDbRwdqlSVdhTY3LFZRVpEjd3C3ODxGyE130_assertion evidence source_evidence_literature NP463182.RAcN3H14xNHHpDbRwdqlSVdhTY3LFZRVpEjd3C3ODxGyE130_provenance.
- NP463182.RAcN3H14xNHHpDbRwdqlSVdhTY3LFZRVpEjd3C3ODxGyE130_assertion SIO_000772 17575113 NP463182.RAcN3H14xNHHpDbRwdqlSVdhTY3LFZRVpEjd3C3ODxGyE130_provenance.
- NP463182.RAcN3H14xNHHpDbRwdqlSVdhTY3LFZRVpEjd3C3ODxGyE130_assertion wasDerivedFrom befree-20140225 NP463182.RAcN3H14xNHHpDbRwdqlSVdhTY3LFZRVpEjd3C3ODxGyE130_provenance.
- NP463182.RAcN3H14xNHHpDbRwdqlSVdhTY3LFZRVpEjd3C3ODxGyE130_assertion wasGeneratedBy ECO_0000203 NP463182.RAcN3H14xNHHpDbRwdqlSVdhTY3LFZRVpEjd3C3ODxGyE130_provenance.